WebJan 12, 2024 · Weeks after canceling its IPO plans, Exton-based Castle Creek Biosciences has acquired Novavita Thera, a Minnesota-based preclinical gene therapy company that focuses on rare liver and metabolic diseases. John George provided details for the Philadelphia Business Journal. The financial terms of the deal were not disclosed. WebJan 10, 2024 · Novavita Thera was acquired by Castle Creek Biosciences on January 10, 2024. Life ScienceCompany. Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Biohaven Pharmaceutical Holding - which was acquired by Pfizer for $11.6B.
Targeting Unmet Needs in Rare Dermatologic Diseases With
WebNovavita thera, a Cytotheryx company, is a biomedical research company focused on the development of a consistent, high-quality source of human hepatocytes (HHCs) and the … WebJan 21, 2024 · Novavita Thera Inc. is a preclinical gene therapy company that is focused on rare liver and metabolic diseases. What This Means By gaining Novavita Thera Inc., Castle Creek Inc. is now able to expand its technology platform by adding in vivo capabilities to its already existing ex vivo approach. slytherin painting ideas
Castle Creek Biosciences Acquires Novavita Thera to …
WebJan 10, 2024 · EXTON, Pa., Jan. 10, 2024 /PRNewswire via COMTEX/ -- EXTON, Pa., Jan. 10, 2024 /PRNewswire/ -- Castle Creek Biosciences, Inc., a late-clinical stage cell and... WebMar 8, 2024 · Nova Vita works to end interpersonal violence and abuse by supporting individuals and families who have experienced domestic violence, intimate partner … WebAug 31, 2024 · Based on this research, Dr. Lillegard co-founded Cytotheryx, Inc., a hepatocyte cell-based therapy company, and Novavita Thera, Inc., a cell and gene therapy company, and served as Chief Scientific Officer and President of both companies. slytherin parents